652,717 Shares in Teladoc Health, Inc. $TDOC Bought by Bank of New York Mellon Corp

Key Points

• Bank of New York Mellon acquired 652,717 Teladoc shares worth approximately $5.5 million, representing about 0.36% of the company. Institutional investors collectively own 76.82% of TDOC.
• Analyst sentiment remains mixed, with a consensus “Hold” rating and an average price target of $7.54. Recent targets range from $7.50 to $10.50.
• Teladoc opened at $6.29 and remains unprofitable, despite beating quarterly EPS estimates; revenue of $606.9 million fell short of forecasts and declined 4% year over year.

Bank of New York Mellon Corp acquired a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 652,717 shares of the health services provider's stock, valued at approximately $5,535,000. Bank of New York Mellon Corp owned about 0.36% of Teladoc Health as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in TDOC. Monaco Asset Management SAM grew its holdings in Teladoc Health by 159.2% in the 4th quarter. Monaco Asset Management SAM now owns 1,956,947 shares of the health services provider's stock worth $13,699,000 after buying an additional 1,201,947 shares in the last quarter. Nano Cap New Millennium Growth Fund L P bought a new stake in Teladoc Health during the fourth quarter worth approximately $1,225,000. Tejara Capital Ltd purchased a new position in Teladoc Health in the 4th quarter worth about $1,114,000. Jupiter Asset Management Ltd. grew its position in Teladoc Health by 293.9% during the 4th quarter. Jupiter Asset Management Ltd. now owns 3,860,076 shares of the health services provider's stock worth $27,021,000 after purchasing an additional 2,880,008 shares in the last quarter. Finally, Pale Fire Capital SE increased its stake in Teladoc Health by 74.8% in the 1st quarter. Pale Fire Capital SE now owns 3,398,491 shares of the health services provider's stock valued at $18,522,000 after buying an additional 1,454,288 shares during the period. 76.82% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have commented on TDOC shares. Weiss Ratings reiterated a "sell (d-)" rating on shares of Teladoc Health in a report on Wednesday, August 19th. Citigroup decreased their target price on shares of Teladoc Health from $11.00 to $7.50 and set a "neutral" rating on the stock in a research report on Monday, August 3rd. Canaccord Genuity Group cut their price objective on Teladoc Health from $11.00 to $10.00 and set a "buy" rating for the company in a report on Thursday, July 30th. Finally, Bank of America raised their price target on Teladoc Health from $9.00 to $10.50 and gave the company a "buy" rating in a report on Tuesday, July 7th. Five investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Teladoc Health has a consensus rating of "Hold" and an average target price of $7.54.

Teladoc Health Stock Performance

Teladoc Health stock opened at $6.29 on Friday. The stock has a fifty day moving average of $7.79 and a 200-day moving average of $6.70. Teladoc Health, Inc. has a 52 week low of $4.40 and a 52 week high of $9.89. The stock has a market capitalization of $1.14 billion, a P/E ratio of -6.35 and a beta of 2.12.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The health services provider reported ($0.21) EPS for the quarter, beating analysts' consensus estimates of ($0.25) by $0.04. The firm had revenue of $606.93 million for the quarter, compared to analyst estimates of $615.44 million. Teladoc Health had a negative return on equity of 12.15% and a negative net margin of 7.13%.The business's revenue for the quarter was down 4.0% on a year-over-year basis. During the same period last year, the firm posted ($0.19) earnings per share. Teladoc Health has set its Q3 2026 guidance at -0.300--0.200 EPS and its FY 2026 guidance at -1.000--0.750 EPS. On average, research analysts forecast that Teladoc Health, Inc. will post -0.89 earnings per share for the current year.

Teladoc Health Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc's service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source